A citation-based method for searching scientific literature


List of co-cited articles
489 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.
Roy F Chemaly, Andrew J Ullmann, Susanne Stoelben, Marie Paule Richard, Martin Bornhäuser, Christoph Groth, Hermann Einsele, Margarida Silverman, Kathleen M Mullane, Janice Brown,[...]. N Engl J Med 2014
232
45

The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.
Thomas Goldner, Guy Hewlett, Nicole Ettischer, Helga Ruebsamen-Schaeff, Holger Zimmermann, Peter Lischka. J Virol 2011
197
41

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
Francisco M Marty, Per Ljungman, Roy F Chemaly, Johan Maertens, Sanjeet S Dadwal, Rafael F Duarte, Shariq Haider, Andrew J Ullmann, Yuta Katayama, Janice Brown,[...]. N Engl J Med 2017
491
41

In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.
Peter Lischka, Guy Hewlett, Tobias Wunberg, Judith Baumeister, Daniela Paulsen, Thomas Goldner, Helga Ruebsamen-Schaeff, Holger Zimmermann. Antimicrob Agents Chemother 2010
162
39

Antiviral drug resistance of human cytomegalovirus.
Nell S Lurain, Sunwen Chou. Clin Microbiol Rev 2010
346
37

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.
Susanne Stoelben, Wolfgang Arns, Lutz Renders, Jürgen Hummel, Anja Mühlfeld, Manfred Stangl, Michael Fischereder, Wilfried Gwinner, Barbara Suwelack, Oliver Witzke,[...]. Transpl Int 2014
94
33

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.
Francisco M Marty, Drew J Winston, Scott D Rowley, Estil Vance, Genovefa A Papanicolaou, Kathleen M Mullane, Thomas M Brundage, Alice T Robertson, Susan Godkin, Hervé Momméja-Marin,[...]. N Engl J Med 2013
240
27


Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.
Francisco M Marty, Per Ljungman, Genovefa A Papanicolaou, Drew J Winston, Roy F Chemaly, Lynne Strasfeld, Jo-Anne H Young, Tulio Rodriguez, Johan Maertens, Michael Schmitt,[...]. Lancet Infect Dis 2011
221
25

First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246.
D R Kaul, S Stoelben, E Cober, T Ojo, E Sandusky, P Lischka, H Zimmermann, H Rubsamen-Schaeff. Am J Transplant 2011
126
25

Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure.
Thomas Goldner, Christine Hempel, Helga Ruebsamen-Schaeff, Holger Zimmermann, Peter Lischka. Antimicrob Agents Chemother 2014
73
25


Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
Pierre Teira, Minoo Battiwalla, Muthalagu Ramanathan, A John Barrett, Kwang Woo Ahn, Min Chen, Jaime S Green, Ayman Saad, Joseph H Antin, Bipin N Savani,[...]. Blood 2016
276
25

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study.
Margaret L Green, Wendy Leisenring, Hu Xie, T Christopher Mast, Yadong Cui, Brenda M Sandmaier, Mohamed L Sorror, Sonia Goyal, Sezen Özkök, Jessica Yi,[...]. Lancet Haematol 2016
209
22

A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.
I Buerger, J Reefschlaeger, W Bender, P Eckenberg, A Popp, O Weber, S Graeper, H D Klenk, H Ruebsamen-Waigmann, S Hallenberger. J Virol 2001
93
18

Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial.
Michael Boeckh, W Garrett Nichols, Roy F Chemaly, Genovefa A Papanicolaou, John R Wingard, Hu Xie, Karen L Syrjala, Mary E D Flowers, Terry Stevens-Ayers, Keith R Jerome,[...]. Ann Intern Med 2015
82
18

The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89.
Eva Maria Borst, Jennifer Kleine-Albers, Ildar Gabaev, Marina Babic, Karen Wagner, Anne Binz, Inga Degenhardt, Markus Kalesse, Stipan Jonjic, Rudolf Bauerfeind,[...]. J Virol 2013
67
16

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.
Karen K Biron, Robert J Harvey, Stanley C Chamberlain, Steven S Good, Albert A Smith, Michelle G Davis, Christine L Talarico, Wayne H Miller, Robert Ferris, Ronna E Dornsife,[...]. Antimicrob Agents Chemother 2002
244
16

In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses.
Manfred Marschall, Thomas Stamminger, Andreas Urban, Steffen Wildum, Helga Ruebsamen-Schaeff, Holger Zimmermann, Peter Lischka. Antimicrob Agents Chemother 2012
75
16

Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects.
Dirk Kropeit, Oliver von Richter, Hans-Peter Stobernack, Helga Rübsamen-Schaeff, Holger Zimmermann. Clin Pharmacol Drug Dev 2018
52
16

Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study.
Oriol Manuel, Shahid Husain, Deepali Kumar, Carlos Zayas, Steve Mawhorter, Marilyn E Levi, Jayant Kalpoe, Luiz Lisboa, Leticia Ely, Daniel R Kaul,[...]. Clin Infect Dis 2013
181
14


Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment.
Dirk Kropeit, Jürgen Scheuenpflug, Katharina Erb-Zohar, Atef Halabi, Hans-Peter Stobernack, Ellen G J Hulskotte, Arne van Schanke, Holger Zimmermann, Helga Rübsamen-Schaeff. Br J Clin Pharmacol 2017
24
29


Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.
Per Ljungman, Ronald Brand, Jennifer Hoek, Rafael de la Camara, Catherine Cordonnier, Hermann Einsele, Jan Styczynski, Katherine N Ward, Simone Cesaro. Clin Infect Dis 2014
143
14

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation.
Camille N Kotton, Deepali Kumar, Angela M Caliendo, Shirish Huprikar, Sunwen Chou, Lara Danziger-Isakov, Atul Humar. Transplantation 2018
433
14

Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection.
Lauren Cherrier, Aasya Nasar, Kellie J Goodlet, Michael D Nailor, Sofya Tokman, Sunwen Chou. Am J Transplant 2018
60
14

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.
Camille N Kotton, Deepali Kumar, Angela M Caliendo, Anders Asberg, Sunwen Chou, Lara Danziger-Isakov, Atul Humar. Transplantation 2013
521
12

Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices.
Veronique Erard, Katherine A Guthrie, Sachiko Seo, Jeremy Smith, MeeiLi Huang, Jason Chien, Mary E D Flowers, Lawrence Corey, Michael Boeckh. Clin Infect Dis 2015
67
12


Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation.
Emily Blyth, Leighton Clancy, Renee Simms, Chun K K Ma, Jane Burgess, Shivashni Deo, Karen Byth, Ming-Celine Dubosq, Peter J Shaw, Kenneth P Micklethwaite,[...]. Blood 2013
159
12

Cytomegalovirus in solid organ transplantation.
R R Razonable, A Humar. Am J Transplant 2013
344
12


Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
R K Avery, F M Marty, L Strasfeld, I Lee, A Arrieta, S Chou, W Tatarowicz, S Villano. Transpl Infect Dis 2010
84
12

Cytomegalovirus in hematopoietic stem cell transplant recipients.
Per Ljungman, Morgan Hakki, Michael Boeckh. Infect Dis Clin North Am 2010
110
12



Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.
Per Ljungman, Michael Boeckh, Hans H Hirsch, Filip Josephson, Jens Lundgren, Garrett Nichols, Andreas Pikis, Raymund R Razonable, Veronica Miller, Paul D Griffiths. Clin Infect Dis 2017
448
12


Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.
Margaret L Green, Wendy Leisenring, Daniel Stachel, Steven A Pergam, Brenda M Sandmaier, Anna Wald, Lawrence Corey, Michael Boeckh. Biol Blood Marrow Transplant 2012
111
12

Antiviral drugs for cytomegalovirus diseases.
Karen K Biron. Antiviral Res 2006
291
12

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.
Robin K Avery, Ravit Arav-Boger, Kieren A Marr, Edward Kraus, Shmuel Shoham, Laura Lees, Brandon Trollinger, Pali Shah, Rich Ambinder, Dionysios Neofytos,[...]. Transplantation 2016
68
12


Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.
Lior Nesher, Dimpy P Shah, Ella J Ariza-Heredia, Jacques M Azzi, Hala K Siddiqui, Shasank S Ghantoji, Lisa Y Marsh, Lamprinos Michailidis, George Makedonas, Katy Rezvani,[...]. J Infect Dis 2016
42
14

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7).
Per Ljungman, Rafael de la Camara, Christine Robin, Roberto Crocchiolo, Hermann Einsele, Joshua A Hill, Petr Hubacek, David Navarro, Catherine Cordonnier, Katherine N Ward. Lancet Infect Dis 2019
147
12

Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial.
D J Winston, F Saliba, E Blumberg, M Abouljoud, J B Garcia-Diaz, J A Goss, L Clough, R Avery, A P Limaye, B G Ericzon,[...]. Am J Transplant 2012
83
10

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.
Drew J Winston, Jo-Anne H Young, Vinod Pullarkat, Genovefa A Papanicolaou, Ravi Vij, Estil Vance, George J Alangaden, Roy F Chemaly, Finn Petersen, Nelson Chao,[...]. Blood 2008
154
10

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
P Ljungman, G L Deliliers, U Platzbecker, S Matthes-Martin, A Bacigalupo, H Einsele, J Ullmann, M Musso, R Trenschel, P Ribaud,[...]. Blood 2001
145
10

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.
Ann M Leen, Catherine M Bollard, Adam M Mendizabal, Elizabeth J Shpall, Paul Szabolcs, Joseph H Antin, Neena Kapoor, Sung-Yun Pai, Scott D Rowley, Partow Kebriaei,[...]. Blood 2013
340
10

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.
Pierre Reusser, Hermann Einsele, John Lee, Liisa Volin, Montserrat Rovira, Dan Engelhard, Jürgen Finke, Catherine Cordonnier, Hartmut Link, Per Ljungman. Blood 2002
204
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.